Actavis, Inc. News Headlines

ACT 
$240.33
*  
3.12
1.32%
Get ACT Alerts
*Delayed - data as of Oct. 24, 2014  -  Find a broker to begin trading ACT now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Will Vertex Pharmaceuticals (VRTX) Post a Lower Q3 Loss? - Analyst Blog
10/24/2014 4:11:00 PM - Zacks.com


Can Epizyme (EPZM) Surprise This Earnings Season? - Analyst Blog
10/24/2014 3:48:00 PM - Zacks.com


Actavis Says US Appeals Court Upholds Patent Of Lo Loestrin Fe
10/23/2014 8:44:00 AM - RTT News


Synergy Pharma presents plecanatide IBS-C clinical trial results
10/21/2014 10:11:00 AM - Seeking Alpha


Digging Deeper Into Valeant's Organic Growth Claims
10/21/2014 7:14:00 AM - Seeking Alpha


PEG Ratio vs. the P/E Ratio - Screen of the Week
10/21/2014 4:14:00 AM - Zacks.com


European Stocks Seen Rising After Solid Apple Earnings
10/21/2014 2:30:00 AM - RTT News


Bloomberg: Actavis Among Final-stage Bidders For Omega Pharmaceuticals
10/20/2014 10:49:00 PM - RTT News


Medical Properties To Buy 40 Rehabilitation Hospitals In Germany For $900 Mln
10/20/2014 10:48:00 PM - RTT News


Why Magnetar Capital exits position in Rosetta Resources
10/17/2014 5:00:00 PM - Market Realist


Ironwood/Actavis Move Linzess into Phase II Study for OIC - Analyst Blog
10/17/2014 4:40:00 PM - Zacks.com


Must-know: Magnetar Capital opens new position in Dish Network
10/17/2014 1:00:00 PM - Market Realist


Aquinox Pharmaceuticals (AQXP) Jumps: Stock Soars 22.4% - Tale of the Tape
10/17/2014 9:27:00 AM - Zacks.com


Why Magnetar Capital initiates new position in Actavis
10/17/2014 9:00:00 AM - Market Realist


Overview: Assessing Magnetar Capital’s 2Q14 positions
10/16/2014 4:51:00 PM - Market Realist


Magnetar Capital adds new position in Williams Companies Inc.
10/16/2014 3:51:00 PM - Market Realist


Actavis Confirms Generic Quillivant XR Patent Litigation
10/16/2014 9:34:00 AM - RTT News


Supernus' Trokendi XR Faces Generic Threat from Zydus - Analyst Blog
10/15/2014 6:45:00 PM - Zacks.com


Mallinckrodt Gives FY15 Guidance Post Questcor Acquisition - Analyst Blog
10/15/2014 5:10:00 PM - Zacks.com


AbbVie To Reconsider Shareholder Recommendation On Inversion Deal For Shire
10/14/2014 10:13:00 PM - RTT News


Pacira (PCRX) Reveals Additional Safety Data on Exparel - Analyst Blog
10/14/2014 5:45:00 PM - Zacks.com


Merger Arbitrage Mondays - October 13, 2014
10/13/2014 12:13:00 PM - Seeking Alpha


AxoGen (AXGN) Shows Strength: Stock Up 15.4% in Session - Tale of the Tape
10/13/2014 9:39:00 AM - Zacks.com


Zacks Rank #1 Additions for Monday - Tale of the Tape
10/13/2014 9:30:00 AM - Zacks.com


Endo to Buy Auxilium for $2.6B, Diversify Portfolio - Analyst Blog
10/10/2014 5:45:00 PM - Zacks.com